Header Logo

Connection

JOHN KIRKWOOD to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Carcinoma, Non-Small-Cell Lung.
JOHN KIRKWOOD
Connection Strength
0.465
Carcinoma, Non-Small-Cell Lung
  1. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma. J Immunother Cancer. 2023 10; 11(10).
    View in: PubMed
    Score: 0.169
  2. Clinical Development of BRAF plus MEK Inhibitor Combinations. Trends Cancer. 2020 09; 6(9):797-810.
    View in: PubMed
    Score: 0.135
  3. A Th1/IFN? Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer. Clin Cancer Res. 2020 04 01; 26(7):1725-1735.
    View in: PubMed
    Score: 0.129
  4. A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586). Lung Cancer. 1999 Sep; 25(3):199-206.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.